Search research articles
Contact Us
Filters
Showing results (81-90 of 186) with videos related to
Page
of 19
Sort By:
BMC Cancer
|
June 8, 2021
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer
Hiromichi Nakajima, Daisuke Kotani, Hideaki Bando, et al.
International Journal of Clinical Oncology
|
June 10, 2025
Physical activity and cancer biology: a narrative review of molecular mechanisms and introduction of the SCRUM-MONSTAR LIFELOG study
Shugo Yajima, Shin Kobayashi, Tadayoshi Hashimoto, et al.
Anticancer Research
|
October 1, 2021
Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective Analysis
Taiko Nakazawa, Yukiya Narita, Ryosuke Kumanishi, et al.
Journal of Gastroenterology
|
May 31, 2024
Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinoma
Takumi Habu, Shogo Kumagai, Hideaki Bando, et al.
Investigational New Drugs
|
May 21, 2021
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II study
Daisuke Kotani, Takayuki Yoshino, Masahito Kotaka, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
January 3, 2023
The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma
Yuki Matsubara, Kazuhiro Toriyama, Shigenori Kadowaki, et al.
Cancer Science
|
March 2, 2026
Single-Cell Analysis Identified a Recurrent Malignant-Associated Transcriptional State in Colorectal Cancer
Sadahiro Iwabuchi, Kentaro Sawada, Motohiro Kojima, et al.
Medical Oncology (Northwood, London, England)
|
January 3, 2012
Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study)
Toshikazu Moriwaki, Hideaki Bando, Atsuo Takashima, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
June 25, 2025
Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy for Very Low-Lying Clinical T3 Rectal Cancer: The NAIR Phase 2/3 Randomized Clinical Trial
Yuichiro Tsukada, Norio Saito, Yuji Nishizawa, et al.
Frontiers in Oncology
|
June 5, 2026
Genomic landscape of immune checkpoint inhibitor-induced aplastic anemia: a case report
Nobuyuki Takahashi, Kenichi Harano, Chikako Funasaka, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 186) with videos related to
Sort By:
Page
of 19
BMC Cancer
|
June 8, 2021
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer
Hiromichi Nakajima, Daisuke Kotani, Hideaki Bando, et al.
International Journal of Clinical Oncology
|
June 10, 2025
Physical activity and cancer biology: a narrative review of molecular mechanisms and introduction of the SCRUM-MONSTAR LIFELOG study
Shugo Yajima, Shin Kobayashi, Tadayoshi Hashimoto, et al.
Anticancer Research
|
October 1, 2021
Second-line Chemotherapy for Previously Treated Metastatic Small Bowel Adenocarcinoma: A Retrospective Analysis
Taiko Nakazawa, Yukiya Narita, Ryosuke Kumanishi, et al.
Journal of Gastroenterology
|
May 31, 2024
Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinoma
Takumi Habu, Shogo Kumagai, Hideaki Bando, et al.
Investigational New Drugs
|
May 21, 2021
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first-line treatment for metastatic colorectal cancer: Safety lead-in results from the QUATTRO-II study
Daisuke Kotani, Takayuki Yoshino, Masahito Kotaka, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
January 3, 2023
The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma
Yuki Matsubara, Kazuhiro Toriyama, Shigenori Kadowaki, et al.
Cancer Science
|
March 2, 2026
Single-Cell Analysis Identified a Recurrent Malignant-Associated Transcriptional State in Colorectal Cancer
Sadahiro Iwabuchi, Kentaro Sawada, Motohiro Kojima, et al.
Medical Oncology (Northwood, London, England)
|
January 3, 2012
Bevacizumab in combination with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) in patients with metastatic colorectal cancer who were previously treated with oxaliplatin-containing regimens: a multicenter observational cohort study (TCTG 2nd-BV study)
Toshikazu Moriwaki, Hideaki Bando, Atsuo Takashima, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
June 25, 2025
Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy for Very Low-Lying Clinical T3 Rectal Cancer: The NAIR Phase 2/3 Randomized Clinical Trial
Yuichiro Tsukada, Norio Saito, Yuji Nishizawa, et al.
Frontiers in Oncology
|
June 5, 2026
Genomic landscape of immune checkpoint inhibitor-induced aplastic anemia: a case report
Nobuyuki Takahashi, Kenichi Harano, Chikako Funasaka, et al.
Page
of 19